Granholm, Anders http://orcid.org/0000-0001-5799-7655
Munch, Marie Warrer
Møller, Morten Hylander
Lange, Theis
Perner, Anders
Funding for this research was provided by:
Novo Nordisk Foundation (0062998)
Rigshospitalet's Research Council (E-22703–06)
Article History
Accepted: 24 December 2021
First Online: 13 January 2022
Declarations
:
: The Department of Intensive Care at Rigshospitalet (AG, MWM, MHM, and AP) has received grants from the Novo Nordisk Foundation during the conduct of the trial; and grants from Pfizer, Fresenius Kabi, The Novo Nordisk Foundation, and Sygeforsikringen “danmark” outside the submitted work.
: Details on ethics approvals of the COVID STEROID 2 trial are presented elsewhere [CitationRef removed–CitationRef removed]. No further approvals were required for this correspondence.